WUXIF (Wuxi AppTec Co) Moat Score: 7/10 (As of Jun. 29, 2026)


WUXIF Wuxi AppTec Co Ltd WUXIF
84 GF Score
Price $15.63
GF Value $11.26
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Moat Score?

Wuxi AppTec Co WUXIF 84 Moat Score is 7 as of Jun. 29, 2026. GuruFocus rates WUXIF with a GF Score™ of 84/100 and a GF Value™ of $11.26 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks better than 97.22% on this metric.

Wuxi AppTec Co has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Wuxi AppTec Co has Wide Moat: Wuxi AppTec benefits from strong market leadership in the contract research organization sector, significant customer switching costs due to integrated services, and valuable intellectual property. Its economies of scale and consistent innovation in R&D further solidify its durable competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Wuxi AppTec Co might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Wuxi AppTec Co  (OTCPK:WUXIF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Wuxi AppTec Co Moat Score Related Terms

WUXIF vs TMO, DHR, IDXX: Moat Score Comparison

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Moat Score falls into.


WUXIF
84GF Score
Wuxi AppTec Co Ltd WUXIF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Wuxi AppTec Co (WUXIF) has a Moat Score of 7 as of Jun. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Wuxi AppTec Co ranks #6 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 2.8%.
Is Wuxi AppTec Co's Moat Score too high?
Wuxi AppTec Co's current Moat Score is 7. Based on the distribution chart, Wuxi AppTec Co ranks #6 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Wuxi AppTec Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Moat Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #6 out of 216 companies for Moat Score. This places Wuxi AppTec Co in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Wuxi AppTec Co's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.26, compared to a current price of $15.63 — trading 38.8% above its estimated fair value. The current Moat Score is 7. Wuxi AppTec Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Moat Score is 7 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of $15.63 is trading 38.8% above its estimated GF Value™ of $11.26. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for WUXIF:

  • Moat Score: 7
  • GF Value™: $11.26 vs. price of $15.63 (38.8% above fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
84GF Score

Get the complete analysis for WUXIF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.63
Price
$11.26
GF Value